- Home
- AKTX vs ZDGE Comparison
AKTX vs ZDGE Comparison
Compare AKTX & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- ZDGE
- Stock Information
- Founded
- AKTX N/A
- ZDGE 2008
- Country
- AKTX United States
- ZDGE United States
- Employees
- AKTX N/A
- ZDGE N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- ZDGE Computer Software: Prepackaged Software
- Sector
- AKTX Health Care
- ZDGE Technology
- Exchange
- AKTX Nasdaq
- ZDGE Nasdaq
- Market Cap
- AKTX 35.7M
- ZDGE 41.7M
- IPO Year
- AKTX N/A
- ZDGE N/A
- Fundamental
- Price
- AKTX $0.84
- ZDGE $3.06
- Analyst Decision
- AKTX Strong Buy
- ZDGE
- Analyst Count
- AKTX 1
- ZDGE 0
- Target Price
- AKTX $5.00
- ZDGE N/A
- AVG Volume (30 Days)
- AKTX 85.8K
- ZDGE 36.3K
- Earning Date
- AKTX 08-13-2025
- ZDGE 10-28-2025
- Dividend Yield
- AKTX N/A
- ZDGE N/A
- EPS Growth
- AKTX N/A
- ZDGE N/A
- EPS
- AKTX N/A
- ZDGE N/A
- Revenue
- AKTX N/A
- ZDGE $29,511,000.00
- Revenue This Year
- AKTX N/A
- ZDGE N/A
- Revenue Next Year
- AKTX N/A
- ZDGE $2.95
- P/E Ratio
- AKTX N/A
- ZDGE N/A
- Revenue Growth
- AKTX N/A
- ZDGE 1.27
- 52 Week Low
- AKTX $0.57
- ZDGE $1.73
- 52 Week High
- AKTX $3.85
- ZDGE $4.89
- Technical
- Relative Strength Index (RSI)
- AKTX 44.86
- ZDGE 39.95
- Support Level
- AKTX $0.57
- ZDGE $2.95
- Resistance Level
- AKTX $1.01
- ZDGE $3.14
- Average True Range (ATR)
- AKTX 0.07
- ZDGE 0.15
- MACD
- AKTX -0.00
- ZDGE 0.02
- Stochastic Oscillator
- AKTX 63.51
- ZDGE 31.43
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.